Mendelspod Podcast

Mendelspod was founded in 2011 by Theral Timpson and Ayanna Monteverdi to advance life science research, connecting people and ideas. Influenced by the thinking tools developed by Eli Goldgratt, the founders bring a unique approach to media in the life sciences. With help from our advisors around the industry, Mendelspod goes beyond quick sound bites to create a space for probing conversations and deep insight into the topics and trends which shape the industry's future and therefore our future as a species.

https://mendelspod.com/

Eine durchschnittliche Folge dieses Podcasts dauert 29m. Bisher sind 498 Folge(n) erschienen. Alle 5 Tage erscheint eine Folge dieses Podcasts.

Gesamtlänge aller Episoden: 59 minutes

subscribe
share





Spatial Biology Enables The Cancer Immunome Project


We’ve all heard of and perhaps worked with data from The Cancer Atlas Project. Now, with the help of new spatial biology tools, researchers at the Mayo Clinic are developing what they call The Cancer Immunome Project. This is a comprehensive effort to fully characterize the immune system and how it interacts with and fights off cancer. Today we talk with J C Villasboas, a physician-scientist at Mayo who co-started the project. He’s also Director of Mayo’s Immune Monitoring Core Facility.


share







   n/a
 
 

Spatial Biology Enables The Immunome Project


We’ve all heard of and perhaps worked with data from The Cancer Atlas Project. Now, with the help of new spatial biology tools, researchers at the Mayo Clinic are developing what they call The Cancer Immunome Project. This is a comprehensive effort to fully characterize the immune system and how it interacts with and fights off cancer. Today we talk with J C Villasboas, a physician-scientist at Mayo who co-started the project. He’s also Director of Mayo’s Immune Monitoring Core Facility.


share







   n/a
 
 

The CRISPR Saga with Kevin Davies


A discovery here. A paper there. An important paper gets passed over. A fortuitous encounter in a coffee shop among two ambitious scientists. A yogurt company just being a yogurt company. Science moves forward in fits and starts. By the time we read the headline in the paper, “breakthrough of the year,” it can have an inevitable quality about it. Then, in a few years, the historian comes and shows us just how random, messy, and, yes, how beautiful is the business of science.


share







 2020-12-22  n/a
 
 

The Story of CRISPR Like You've Never Read It with Kevin Davies


A discovery here. A paper there. An important paper gets passed over. A fortuitous encounter in a coffee shop among two ambitious scientists. A yogurt company just being a yogurt company. Science moves forward in fits and starts. By the time we read the headline in the paper, “breakthrough of the year,” it can have an inevitable quality about it. Then, in a few years, the historian comes and shows us just how random, messy, and, yes, how beautiful is the business of science.


share







 2020-12-22  n/a
 
 

PacBio’s Never Been Stronger: New CEO, Christian Henry, Shares His Vision


At the beginning of the year, we were all holding our breath for the future of PacBio. And by all, I mean all. It seems everyone has been rooting for this sequencing technology company. And why? It’s simple. Pretty much everyone is in agreement that they have the highest quality reads on the market.


share







 2020-12-15  n/a
 
 

Keith Robison on the State of Sequencing: 2020 Edition


We speak directly with the Oracle today. It's Keith Robison, blogger at Omics Omics. Your All Knowingness, we ask, what has happened in the world of sequencing technology this year? “The companies may need a mulligan,” he quips and laughs.


share







 2020-11-17  n/a
 
 

Keith Robison gives his State of Sequencing: 2020 Edition


We speak directly with the Oracle today. It's Keith Robison, blogger at Omics Omics. Your All Knowingness, we ask, what has happened in the world of sequencing technology this year? “The companies may need a mulligan,” he quips and laughs.


share







 2020-11-17  n/a
 
 

Halloween with Nathan and Laura: The Spooky and Creepy of Genomics


Our October Review show is a Halloween special this year. Join us around the campfire amidst the sounds of howling wolves as Nathan, Laura, and Count Theracula recall some of their creepiest and spookiest times in the world of genomics. It's Mendelspod's own Haunted House of the Genome.


share







 2020-10-30  n/a
 
 

When and Why Whole Genome Sequencing Should Be Standard of Care: Stephen Kingsmore of Rady Children’s


There’s an urgency about Stephen Kingsmore. Which is not to say he’s in a rush. He’s the CEO of the Rady’s Children’s Genomics Institute. He and his team have two world records to their name for the incredible speed of diagnosing a rare disease using whole genome sequencing. The latest is 19.5 hours. Dr. Kingsmore feels they can even shave time off that. They’re shooting for a new record of somewhere around 12 hours.


share







 2020-10-27  n/a
 
 

Limited Genetic Diversity Affects Us All


Diversity’s in the news these days. It's not just political correctness. Let’s look deeper into our field at how limited diversity in genetics is affecting all of us. If you are a member of a minority population and you go into a cancer clinic seeking help, some of the genetic tests on offer may not work for you because of your ethnic background. Not only is this wrong on a social justice level. It turns out it's just bad science.


share







 2020-10-22  n/a